Table 3.
Description of the pharmacist interventions according to the DEPICT version 2.
| Author | Recipient | Contact with recipient | Methods of communication | Setting of the intervention | Action(s) taken by pharmacist | Materials that support action(s) |
|---|---|---|---|---|---|---|
| Arain et al.19 | Patient and HCP | One-to-one (patient and HCP) and group (HCP) | Face-to-face (patient and HCP), written (patient and HCP), and telephone (HCP) | Hospital bedside (patient and HCP), hospital pharmacy (HCP), and ambulatory setting (patient) | Drug information for HCP; patient counseling; suggestion for change in therapy; monitoring results report; drug supply management; safety measures for infection control | Discharge letter; educational materials; protocol; safety alert system |
| Elson et al.20 | Patient and HCP | One-to-one (patient) and group (HCP) | Written (patient and HCP), telephone (patient and HCP), and video conference (patient and HCP) | Hospital bedside (patients and HCP), ambulatory setting (patient), and recipient's home (patient) | Drug information for HCP; patient counseling; drug supply management | NR |
| Fan and Kamath21 | Patient and HCP | One-to-one (patient) and group (HCP) | Video conference (patient and HCP) | Hospital bedside (patients and HCP) and recipient's home (patient) | Drug information for HCP; patient counseling | NR |
| Hua et al.22 | Patient and HCP | One-to-one (patient and HCP) and group (patient) | Written (patient and HCP), telephone (patient), video conference (patient), and radio station (patient) | Hospital bedside (patient and HCP) | Drug information for HCP; patient counseling; drug supply management | NR |
| Meng et al.23 | Patient and HCP | One-to-one (patient and HCP) | Telephone and video conference (patient and HCP) | Hospital bedside (patient and HCP) | Drug information for HCP; patient counseling; drug supply management; safety measures for infection control | Educational materials |
| Ou and Yang24 | NAa | One-to-one | Face-to-face | Community pharmacy | Safety measures for infection control | NR |
| Tan et al.25 | Patient | One-to-one | NR | Recipient's home | Patient counseling; suggestion for change in therapy | NR |
| Ung26 | NAa | One-to-one | Face-to-face | Community pharmacy | Safety measures for infection control | NR |
| Yemm et al.27 | Patient | One-to-one | Telephone | Recipient's home | Application of tools to evaluated a disease | NR |
| Ying et al.28 | Patient and HPC | One-to-one (patient and HPC) and group (HPC) | Face-to-face, written (patient and HPC) | Hospital bedside (patient and HCP) and ambulatory setting (patient and HCP) | Drug information for HPC; patient counseling; drug supply management; safety measures for infection control | Educational materials |
| Zuckerman et al.29 | Patient and HCP | One-to-one (patient and HCP) and group (HCP) | Written (patients and HCP), telephone (patients), and video conference (HCP) | Hospital bedside (patient and HCP), hospital pharmacy (HCP), ambulatory setting (patient and HCP) and recipient's home (patient) | Drug information for HPC; patient counseling; suggestion for change in therapy; drug supply management; safety measures for infection control | Educational materials; protocols |
Abbreviation: HCP (healthcare professionals), NA (not applicable), NR (not reported).
a
Pharmacist interventions were conducted for the general population.